Rainmed Medical Limited (RAINMED-B) aksje
2297.HK
StengtRAINMED-B
Market Cap
$277,469,056
Om Rainmed Medical Limited (RAINMED-B) aksje
Rainmed Medical Limited operates as a vascular interventional surgical robotics company in China and internationally. It engages in the research and development, manufacturing, and commercialization of medical instruments related to coronary angiography-derived fractional flow reserve (caFFR) systems and coronary angiography-derived index of microvascular resistance (caIMR) systems. The company also offers FlashAngio caFFR System, a coronary angiography-derived fractional flow reserve measurement system; FlashAngio caIMR System, which provides auxiliary diagnosis of coronary artery diseases; and disposable blood pressure transducer, which is used in conjunction with specialized equipment. In addition, it provides reagents and others installation and training services. Rainmed Medical Limited was founded in 2014 and is headquartered in Suzhou, China.
Selskapsinformasjon
215000 Suzhou, China
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.